These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure. Isenman DE, Leung E, Mackay JD, Bagby S, van den Elsen JM. J Immunol; 2010 Feb 15; 184(4):1946-55. PubMed ID: 20083651 [Abstract] [Full Text] [Related]
10. Structure of complement receptor 2 in complex with its C3d ligand. Szakonyi G, Guthridge JM, Li D, Young K, Holers VM, Chen XS. Science; 2001 Jun 01; 292(5522):1725-8. PubMed ID: 11387479 [Abstract] [Full Text] [Related]
11. The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding. Prota AE, Sage DR, Stehle T, Fingeroth JD. Proc Natl Acad Sci U S A; 2002 Aug 06; 99(16):10641-6. PubMed ID: 12122212 [Abstract] [Full Text] [Related]
12. Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study. Gilbert HE, Eaton JT, Hannan JP, Holers VM, Perkins SJ. J Mol Biol; 2005 Feb 25; 346(3):859-73. PubMed ID: 15713468 [Abstract] [Full Text] [Related]
13. Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg. Guthridge JM, Rakstang JK, Young KA, Hinshelwood J, Aslam M, Robertson A, Gipson MG, Sarrias MR, Moore WT, Meagher M, Karp D, Lambris JD, Perkins SJ, Holers VM. Biochemistry; 2001 May 22; 40(20):5931-41. PubMed ID: 11352728 [Abstract] [Full Text] [Related]
16. A crystal structure of the complex between human complement receptor 2 and its ligand C3d. van den Elsen JM, Isenman DE. Science; 2011 Apr 29; 332(6029):608-11. PubMed ID: 21527715 [Abstract] [Full Text] [Related]
17. A theoretical view of the C3d:CR2 binding controversy. Mohan RR, Gorham RD, Morikis D. Mol Immunol; 2015 Mar 29; 64(1):112-22. PubMed ID: 25433434 [Abstract] [Full Text] [Related]
18. Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus. Asokan R, Hua J, Young KA, Gould HJ, Hannan JP, Kraus DM, Szakonyi G, Grundy GJ, Chen XS, Crow MK, Holers VM. J Immunol; 2006 Jul 01; 177(1):383-94. PubMed ID: 16785534 [Abstract] [Full Text] [Related]
19. Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d. Wan H, Hu JP, Tian XH, Chang S. Phys Chem Chem Phys; 2013 Jan 28; 15(4):1241-51. PubMed ID: 23229122 [Abstract] [Full Text] [Related]
20. The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21). Hannan JP. Curr Protein Pept Sci; 2016 Jan 28; 17(5):463-87. PubMed ID: 26916158 [Abstract] [Full Text] [Related] Page: [Next] [New Search]